These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19436305)

  • 1. Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
    Cambien B; Karimdjee BF; Richard-Fiardo P; Bziouech H; Barthel R; Millet MA; Martini V; Birnbaum D; Scoazec JY; Abello J; Al Saati T; Johnson MG; Sullivan TJ; Medina JC; Collins TL; Schmid-Alliana A; Schmid-Antomarchi H
    Br J Cancer; 2009 Jun; 100(11):1755-64. PubMed ID: 19436305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver.
    Guillemot E; Karimdjee-Soilihi B; Pradelli E; Benchetrit M; Goguet-Surmenian E; Millet MA; Larbret F; Michiels JF; Birnbaum D; Alemanno P; Schmid-Antomarchi H; Schmid-Alliana A
    Br J Cancer; 2012 Dec; 107(12):1944-9. PubMed ID: 23169289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CXCR3 and CXCR4 in colorectal cancer metastasis.
    Murakami T; Kawada K; Iwamoto M; Akagami M; Hida K; Nakanishi Y; Kanda K; Kawada M; Seno H; Taketo MM; Sakai Y
    Int J Cancer; 2013 Jan; 132(2):276-87. PubMed ID: 22689289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs.
    Pradelli E; Karimdjee-Soilihi B; Michiels JF; Ricci JE; Millet MA; Vandenbos F; Sullivan TJ; Collins TL; Johnson MG; Medina JC; Kleinerman ES; Schmid-Alliana A; Schmid-Antomarchi H
    Int J Cancer; 2009 Dec; 125(11):2586-94. PubMed ID: 19544560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
    Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
    Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3 expression in colorectal cancer cells enhanced invasion through preventing CXCR4 internalization.
    Jin J; Zhang Z; Wang H; Zhan Y; Li G; Yang H; Fei Z; Xu Y; Li W
    Exp Cell Res; 2018 Oct; 371(1):162-174. PubMed ID: 30092218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes.
    Kawada K; Hosogi H; Sonoshita M; Sakashita H; Manabe T; Shimahara Y; Sakai Y; Takabayashi A; Oshima M; Taketo MM
    Oncogene; 2007 Jul; 26(32):4679-88. PubMed ID: 17297455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines.
    Chowdhury S; Ongchin M; Sharratt E; Dominguez I; Wang J; Brattain MG; Rajput A
    PLoS One; 2013; 8(4):e60299. PubMed ID: 23560089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
    Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
    Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.
    Maekawa S; Iwasaki A; Shirakusa T; Kawakami T; Yanagisawa J; Tanaka T; Shibaguchi H; Kinugasa T; Kuroki M; Kuroki M
    Oncol Rep; 2008 Jun; 19(6):1461-8. PubMed ID: 18497951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer.
    Yamaki M; Shinozaki K; Sakaguchi T; Meseck M; Ebert O; Ohdan H; Woo SL
    Int J Mol Med; 2013 Feb; 31(2):299-306. PubMed ID: 23232984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.
    Ma X; Norsworthy K; Kundu N; Rodgers WH; Gimotty PA; Goloubeva O; Lipsky M; Li Y; Holt D; Fulton A
    Mol Cancer Ther; 2009 Mar; 8(3):490-8. PubMed ID: 19276169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-γ-inducible Chemokines.
    Djaafar S; Dunand-Sautier I; Gonelle-Gispert C; Lacotte S; DE Agostini A; Petro M; Rubbia-Brandt L; Morel P; Toso C; Mentha G
    Anticancer Res; 2016 Aug; 36(8):4019-32. PubMed ID: 27466508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.
    Meijer J; Zeelenberg IS; Sipos B; Roos E
    Cancer Res; 2006 Oct; 66(19):9576-82. PubMed ID: 17018614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model.
    Miao S; Tang B; Liu H; Wang Z; Shi Y; Dong Y; Liu W; Qin C; Ren H
    Mol Immunol; 2018 Feb; 94():82-90. PubMed ID: 29288898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cells inhibit CD8
    Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
    J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity.
    Zhu G; Yan HH; Pang Y; Jian J; Achyut BR; Liang X; Weiss JM; Wiltrout RH; Hollander MC; Yang L
    Oncotarget; 2015 Dec; 6(41):43408-19. PubMed ID: 26485767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.